Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer

Affiliations

• ¹ Davidoff Cancer Center, Rabin Medical Center, Petach Tikvah, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
• ² Davidoff Cancer Center, Rabin Medical Center, Petach Tikvah, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Clalit Health Service, Tel Aviv, Israel; Optimal Cancer Care Alliance, Ann Arbor, MI, USA.
• ³ Division of Cancer Care and Epidemiology & Departments of Oncology and Public Health Sciences, Queen's University Cancer Research Institute, Kingston, ON, Canada.
• ⁴ Optimal Cancer Care Alliance, Ann Arbor, MI, USA; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada. Electronic address: ian.tannock@uhn.ca.